VRCA Verrica Pharmaceuticals and medomie Pharma enter into exclusive distribution, marketing and supply agreement to commercialize ycanth® f

VRCA Verrica Pharmaceuticals and medomie Pharma enter into exclusive distribution, marketing and supply agreement to commercialize ycanth® for the treatment of molluscum contagiosum in Israel Verrica Pharmaceuticals: granted medomie exclusive right to obtain & maintain marketing authorizations for ycanth in Israel Verrica Pharmaceuticals Inc: will receive 60% of net selling price of product sold by medomie in Israel - Eligible to receive up to $8.2M in total regulatory and commercial milestones